The first international conference on SYNGAP1-related brain disorders: a stakeholder meeting of families, researchers, clinicians, and regulators
Open Access
- 5 February 2018
- journal article
- review article
- Published by Springer Nature in Journal of Neurodevelopmental Disorders
- Vol. 10 (1) , 6
Abstract
Pathologic mutations in SYNGAP1 cause a genetically defined form of intellectual disability (ID) with comorbid epilepsy and autistic features. While only recently discovered, pathogenicity of this gene is a relatively frequent genetic cause of classically undefined developmental delay that progresses to ID with commonly occurring comorbidities. A meeting of 150 people was held that included affected individuals and their caregivers, clinicians that treat this and related brain disorders, neuroscientists that study SYNGAP1 biology or the function of related genes, and representatives from government agencies that fund science and approve new medical treatments. The meeting focused on developing a consensus among all stakeholders as to how best to achieve a more fundamental and profound understanding of SYNGAP1 biology and its role in human disease. From all of these proceedings, several areas of consensus emerged. The clinicians and geneticists agreed that the prevalence of epilepsy and sensory processing impairments in SYNGAP1-related brain disorders approached 100%. The neurobiologists agreed that more basic research is needed to better understand the molecular and cellular functions of the Syngap1 gene, which will lead to targets for therapeutic intervention. Finally, everyone agreed that there is a pressing need to form a robust patient registry as an initial step toward a prospective natural history study of patients with pathogenic SYNGAP1 variants.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (R13NS098727)
This publication has 42 references indexed in Scilit:
- Mutations inSYNGAP1Cause Intellectual Disability, Autism, and a Specific Form of Epilepsy by Inducing HaploinsufficiencyHuman Mutation, 2012
- Pathogenic SYNGAP1 Mutations Impair Cognitive Development by Disrupting Maturation of Dendritic Spine SynapsesCell, 2012
- De Novo SYNGAP1 Mutations in Nonsyndromic Intellectual Disability and AutismBiological Psychiatry, 2011
- Characterization of the proteome, diseases and evolution of the human postsynaptic densityNature Neuroscience, 2010
- Functional impact of global rare copy number variation in autism spectrum disordersNature, 2010
- Mutations inSYNGAP1in Autosomal Nonsyndromic Mental RetardationNew England Journal of Medicine, 2009
- Reduced Expression of the NMDA Receptor-Interacting Protein SynGAP Causes Behavioral Abnormalities that Model Symptoms of SchizophreniaNeuropsychopharmacology, 2009
- Neurofibromin Regulation of ERK Signaling Modulates GABA Release and LearningCell, 2008
- SynGAP-MUPP1-CaMKII Synaptic Complexes Regulate p38 MAP Kinase Activity and NMDA Receptor- Dependent Synaptic AMPA Receptor PotentiationNeuron, 2004
- Role of Unc51.1 and its binding partners in CNS axon outgrowthGenes & Development, 2004